Morgan Stanley downgrades Travelers to Underweight, cuts target to $290
Morgan Stanley analyst Bob Huang downgraded Travelers Companies to Underweight from Equal-Weight and reduced the price target to $290 from $333. This update is part of a broader trend of analyst adjustments for the NYSE-listed insurer.
*this image is generated using AI for illustrative purposes only.
Morgan Stanley analyst Bob Huang has downgraded Travelers Companies to Underweight from Equal-Weight and lowered the price target to $290 from $333. This revision signals a more cautious outlook on the insurance provider, which trades on the NYSE under the ticker TRV. The adjustment follows a series of rating and target changes by major financial institutions analyzing the stock's valuation and market performance.
Rating and Price Target
The research note revises the investment stance on Travelers Companies, shifting from a neutral view to a negative recommendation. The table below summarizes the recent analyst actions:
| Firm | Analyst | Rating | Price Target | Previous Target |
|---|---|---|---|---|
| Morgan Stanley | Bob Huang | Underweight | $290 | $333 |
| Evercore ISI Group | David Motemaden | In-Line | $329 | $321 |
| Wells Fargo | Elyse Greenspan | Equal-Weight | $334 | $295 |
| Mizuho | Yaron Kinar | Neutral | $324 | $304 |
| Raymond James | C. Gregory Peters | Strong Buy | $400 | $350 |
What specific factors led Morgan Stanley to adopt a more cautious outlook on Travelers Companies?
How might the downgrade impact Travelers' stock performance in the near term?
What are the broader market conditions influencing analyst sentiment on the insurance sector?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
